Elekta AB (publ) (OTCMKTS:EKTAY) Short Interest Down 99.5% in January

Elekta AB (publ) (OTCMKTS:EKTAYGet Free Report) was the target of a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 100 shares, a drop of 99.5% from the January 15th total of 19,700 shares. Based on an average daily trading volume, of 16,900 shares, the short-interest ratio is currently 0.0 days.

Elekta AB (publ) Trading Up 1.4 %

EKTAY opened at $6.00 on Thursday. Elekta AB has a 1-year low of $5.25 and a 1-year high of $8.24. The company has a current ratio of 1.05, a quick ratio of 0.81 and a debt-to-equity ratio of 0.60. The company has a market cap of $2.30 billion, a P/E ratio of 23.98 and a beta of 1.22. The company has a fifty day moving average price of $5.66 and a two-hundred day moving average price of $6.09.

Elekta AB (publ) (OTCMKTS:EKTAYGet Free Report) last posted its quarterly earnings results on Wednesday, November 27th. The company reported $0.06 earnings per share for the quarter. Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. Analysts predict that Elekta AB will post 0.36 EPS for the current fiscal year.

Elekta AB (publ) Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, March 27th. Stockholders of record on Friday, March 7th will be given a dividend of $0.1072 per share. The ex-dividend date of this dividend is Friday, March 7th. Elekta AB (publ)’s payout ratio is presently 48.00%.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a research note on Wednesday, January 29th.

View Our Latest Research Report on Elekta AB (publ)

About Elekta AB (publ)

(Get Free Report)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

Read More

Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.